Lawyer profile
Matthew Warner
Clifford Chance
- Firm
- Clifford Chance
- Practice
- Corporate, corporate M&A, healthcare and US investment
- Office
- New York
- Active in the record
- 2021 to 2026
Deal experience
Recent deals
13 announced deals in the record Clifford Chance advises U.S. Department of Commerce on US$1 billion CHIPS Act Award to Anderon for quantum semiconductor foundry development 21 Sept 2026
Clifford Chance advises Mitsui and Nutrinova on strategic upstream integration and expansion of Mitsui’s investment in Nutrinova 3 Sept 2026
Clifford Chance advises Sanofi on acquisition of exclusive Greater China rights to develop and commercialise aficamten 20 Jan 2025
Clifford Chance advises Keymed Biosciences Inc. on out-licensing transaction with Belenos Biosciences 14 Aug 2024
Clifford Chance advised on business combination between Pegasus and SCHMID Group and listing of SCHMID Group N.V. on NASDAQ 16 May 2024
Clifford Chance advises ADB on financing to Greenway subsidiary for carbon offset project in India 11 Dec 2023
Clifford Chance advises Mitsui on its US$472.5 million majority acquisition of Celanese’s Food Ingredients Business 4 Jul 2023
Clifford Chance advises BlackRock on US$150 million financing 13 Oct 2022
Clifford Chance advises Informa on US$193 million sale of several business units to Montagu 22 Jul 2022
Clifford Chance advises BlackRock on US$300 million financing 7 Feb 2022
Deal alerts PRO
Get an email when Matthew Warner is named on a newly announced deal.
Alerts come as one daily email at most.
Analytics
Based on announced deals in DealDatabaseLoading analytics…
Complete deal history
Is this you?
Claim your profile to add your title, a biography and a photo, and show a verified badge. It is free.
Claim this profile